Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Buy
86
INDV Quote, Financials, Valuation and Earnings
Last price:
$35.41
Seasonality move
:
5.95%
Day range:
$33.76 - $35.82
52-week range:
$7.62 - $38.00
Dividend yield:
0%
P/E ratio:
35.28x
P/S ratio:
3.79x
P/B ratio:
238.64x
Volume:
2.6M
Avg. volume:
2.9M
1-year change:
193.13%
Market cap:
$4.4B
Revenue:
$1.2B
EPS (TTM):
$1.00
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
INDV
Indivior PLC
|
$269.5M | $0.67 | 1.33% | 77.31% | $41.00 |
|
APYX
Apyx Medical Corp.
|
$10.2M | -$0.12 | 22.81% | -50.45% | $6.00 |
|
CRMD
CorMedix, Inc.
|
$117.4M | $0.57 | 200.36% | 90.44% | $17.71 |
|
NEPH
Nephros, Inc.
|
$5.1M | $0.04 | 15.01% | -69.79% | $6.50 |
|
OWLT
Owlet, Inc.
|
$26.2M | -$0.12 | 24.19% | -81.11% | $17.00 |
|
VTRS
Viatris, Inc.
|
$3.3B | $0.55 | 2.07% | 681.52% | $12.7778 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
INDV
Indivior PLC
|
$35.44 | $41.00 | $4.4B | 35.28x | $0.00 | 0% | 3.79x |
|
APYX
Apyx Medical Corp.
|
$3.49 | $6.00 | $133.5M | -- | $0.00 | 0% | 2.92x |
|
CRMD
CorMedix, Inc.
|
$7.63 | $17.71 | $601.2M | 3.72x | $0.00 | 0% | 2.57x |
|
NEPH
Nephros, Inc.
|
$4.81 | $6.50 | $51.1M | 34.83x | $0.00 | 0% | 2.89x |
|
OWLT
Owlet, Inc.
|
$15.83 | $17.00 | $436.6M | -- | $0.00 | 0% | 2.65x |
|
VTRS
Viatris, Inc.
|
$12.7600 | $12.7778 | $14.7B | -- | $0.12 | 3.76% | 1.07x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
INDV
Indivior PLC
|
238.93% | 1.215 | 11.83% | 0.73x |
|
APYX
Apyx Medical Corp.
|
87.02% | 4.561 | 48.31% | 3.58x |
|
CRMD
CorMedix, Inc.
|
1.16% | 2.954 | 0.48% | 1.60x |
|
NEPH
Nephros, Inc.
|
10.34% | 3.066 | 2.3% | 3.17x |
|
OWLT
Owlet, Inc.
|
-182.74% | 3.541 | 16.06% | 0.85x |
|
VTRS
Viatris, Inc.
|
49.17% | 0.761 | 128.3% | 0.55x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
INDV
Indivior PLC
|
$252M | $99M | 130.39% | 14.29% | 31.53% | -$62.4M |
|
APYX
Apyx Medical Corp.
|
$5.1M | -$832K | -29.7% | -146.08% | -6.46% | -$4.1M |
|
CRMD
CorMedix, Inc.
|
$93.1M | $51.3M | 94.54% | 95.25% | 49.24% | $30.4M |
|
NEPH
Nephros, Inc.
|
$2.9M | $314K | 14.16% | 16.22% | 6.59% | $99K |
|
OWLT
Owlet, Inc.
|
$16.2M | $1.2M | -- | -- | 3.8% | -$2.6M |
|
VTRS
Viatris, Inc.
|
$1.4B | $317.4M | -11.6% | -21.75% | 8.44% | $645.2M |
Indivior PLC vs. Competitors
-
Which has Higher Returns INDV or APYX?
Apyx Medical Corp. has a net margin of 13.38% compared to Indivior PLC's net margin of -15.18%. Indivior PLC's return on equity of 14.29% beat Apyx Medical Corp.'s return on equity of -146.08%.
Company Gross Margin Earnings Per Share Invested Capital INDVIndivior PLC80.26% $0.33 $149M APYXApyx Medical Corp.39.65% -$0.05 $45.3M -
What do Analysts Say About INDV or APYX?
Indivior PLC has a consensus price target of $41.00, signalling upside risk potential of 15.69%. On the other hand Apyx Medical Corp. has an analysts' consensus of $6.00 which suggests that it could grow by 71.92%. Given that Apyx Medical Corp. has higher upside potential than Indivior PLC, analysts believe Apyx Medical Corp. is more attractive than Indivior PLC.
Company Buy Ratings Hold Ratings Sell Ratings INDVIndivior PLC5 0 0 APYXApyx Medical Corp.3 1 0 -
Is INDV or APYX More Risky?
Indivior PLC has a beta of 1.098, which suggesting that the stock is 9.798% more volatile than S&P 500. In comparison Apyx Medical Corp. has a beta of 1.529, suggesting its more volatile than the S&P 500 by 52.874%.
-
Which is a Better Dividend Stock INDV or APYX?
Indivior PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Apyx Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Indivior PLC pays -- of its earnings as a dividend. Apyx Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INDV or APYX?
Indivior PLC quarterly revenues are $314M, which are larger than Apyx Medical Corp. quarterly revenues of $12.9M. Indivior PLC's net income of $42M is higher than Apyx Medical Corp.'s net income of -$2M. Notably, Indivior PLC's price-to-earnings ratio is 35.28x while Apyx Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Indivior PLC is 3.79x versus 2.92x for Apyx Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INDVIndivior PLC3.79x 35.28x $314M $42M APYXApyx Medical Corp.2.92x -- $12.9M -$2M
-
Which has Higher Returns INDV or CRMD?
CorMedix, Inc. has a net margin of 13.38% compared to Indivior PLC's net margin of 49.9%. Indivior PLC's return on equity of 14.29% beat CorMedix, Inc.'s return on equity of 95.25%.
Company Gross Margin Earnings Per Share Invested Capital INDVIndivior PLC80.26% $0.33 $149M CRMDCorMedix, Inc.89.26% $1.26 $378.5M -
What do Analysts Say About INDV or CRMD?
Indivior PLC has a consensus price target of $41.00, signalling upside risk potential of 15.69%. On the other hand CorMedix, Inc. has an analysts' consensus of $17.71 which suggests that it could grow by 132.17%. Given that CorMedix, Inc. has higher upside potential than Indivior PLC, analysts believe CorMedix, Inc. is more attractive than Indivior PLC.
Company Buy Ratings Hold Ratings Sell Ratings INDVIndivior PLC5 0 0 CRMDCorMedix, Inc.4 0 0 -
Is INDV or CRMD More Risky?
Indivior PLC has a beta of 1.098, which suggesting that the stock is 9.798% more volatile than S&P 500. In comparison CorMedix, Inc. has a beta of 1.358, suggesting its more volatile than the S&P 500 by 35.753%.
-
Which is a Better Dividend Stock INDV or CRMD?
Indivior PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CorMedix, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Indivior PLC pays -- of its earnings as a dividend. CorMedix, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INDV or CRMD?
Indivior PLC quarterly revenues are $314M, which are larger than CorMedix, Inc. quarterly revenues of $104.3M. Indivior PLC's net income of $42M is lower than CorMedix, Inc.'s net income of $108.6M. Notably, Indivior PLC's price-to-earnings ratio is 35.28x while CorMedix, Inc.'s PE ratio is 3.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Indivior PLC is 3.79x versus 2.57x for CorMedix, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INDVIndivior PLC3.79x 35.28x $314M $42M CRMDCorMedix, Inc.2.57x 3.72x $104.3M $108.6M
-
Which has Higher Returns INDV or NEPH?
Nephros, Inc. has a net margin of 13.38% compared to Indivior PLC's net margin of 7.07%. Indivior PLC's return on equity of 14.29% beat Nephros, Inc.'s return on equity of 16.22%.
Company Gross Margin Earnings Per Share Invested Capital INDVIndivior PLC80.26% $0.33 $149M NEPHNephros, Inc.60.47% $0.03 $11.2M -
What do Analysts Say About INDV or NEPH?
Indivior PLC has a consensus price target of $41.00, signalling upside risk potential of 15.69%. On the other hand Nephros, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 35.14%. Given that Nephros, Inc. has higher upside potential than Indivior PLC, analysts believe Nephros, Inc. is more attractive than Indivior PLC.
Company Buy Ratings Hold Ratings Sell Ratings INDVIndivior PLC5 0 0 NEPHNephros, Inc.1 0 0 -
Is INDV or NEPH More Risky?
Indivior PLC has a beta of 1.098, which suggesting that the stock is 9.798% more volatile than S&P 500. In comparison Nephros, Inc. has a beta of 1.407, suggesting its more volatile than the S&P 500 by 40.722%.
-
Which is a Better Dividend Stock INDV or NEPH?
Indivior PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nephros, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Indivior PLC pays -- of its earnings as a dividend. Nephros, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INDV or NEPH?
Indivior PLC quarterly revenues are $314M, which are larger than Nephros, Inc. quarterly revenues of $4.8M. Indivior PLC's net income of $42M is higher than Nephros, Inc.'s net income of $337K. Notably, Indivior PLC's price-to-earnings ratio is 35.28x while Nephros, Inc.'s PE ratio is 34.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Indivior PLC is 3.79x versus 2.89x for Nephros, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INDVIndivior PLC3.79x 35.28x $314M $42M NEPHNephros, Inc.2.89x 34.83x $4.8M $337K
-
Which has Higher Returns INDV or OWLT?
Owlet, Inc. has a net margin of 13.38% compared to Indivior PLC's net margin of 12.58%. Indivior PLC's return on equity of 14.29% beat Owlet, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital INDVIndivior PLC80.26% $0.33 $149M OWLTOwlet, Inc.50.51% $0.13 -$13.7M -
What do Analysts Say About INDV or OWLT?
Indivior PLC has a consensus price target of $41.00, signalling upside risk potential of 15.69%. On the other hand Owlet, Inc. has an analysts' consensus of $17.00 which suggests that it could grow by 7.39%. Given that Indivior PLC has higher upside potential than Owlet, Inc., analysts believe Indivior PLC is more attractive than Owlet, Inc..
Company Buy Ratings Hold Ratings Sell Ratings INDVIndivior PLC5 0 0 OWLTOwlet, Inc.5 0 0 -
Is INDV or OWLT More Risky?
Indivior PLC has a beta of 1.098, which suggesting that the stock is 9.798% more volatile than S&P 500. In comparison Owlet, Inc. has a beta of 1.706, suggesting its more volatile than the S&P 500 by 70.642%.
-
Which is a Better Dividend Stock INDV or OWLT?
Indivior PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Owlet, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Indivior PLC pays -- of its earnings as a dividend. Owlet, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INDV or OWLT?
Indivior PLC quarterly revenues are $314M, which are larger than Owlet, Inc. quarterly revenues of $32M. Indivior PLC's net income of $42M is higher than Owlet, Inc.'s net income of $4M. Notably, Indivior PLC's price-to-earnings ratio is 35.28x while Owlet, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Indivior PLC is 3.79x versus 2.65x for Owlet, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INDVIndivior PLC3.79x 35.28x $314M $42M OWLTOwlet, Inc.2.65x -- $32M $4M
-
Which has Higher Returns INDV or VTRS?
Viatris, Inc. has a net margin of 13.38% compared to Indivior PLC's net margin of -3.41%. Indivior PLC's return on equity of 14.29% beat Viatris, Inc.'s return on equity of -21.75%.
Company Gross Margin Earnings Per Share Invested Capital INDVIndivior PLC80.26% $0.33 $149M VTRSViatris, Inc.36.87% -$0.11 $29.9B -
What do Analysts Say About INDV or VTRS?
Indivior PLC has a consensus price target of $41.00, signalling upside risk potential of 15.69%. On the other hand Viatris, Inc. has an analysts' consensus of $12.7778 which suggests that it could grow by 0.14%. Given that Indivior PLC has higher upside potential than Viatris, Inc., analysts believe Indivior PLC is more attractive than Viatris, Inc..
Company Buy Ratings Hold Ratings Sell Ratings INDVIndivior PLC5 0 0 VTRSViatris, Inc.3 6 0 -
Is INDV or VTRS More Risky?
Indivior PLC has a beta of 1.098, which suggesting that the stock is 9.798% more volatile than S&P 500. In comparison Viatris, Inc. has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.679%.
-
Which is a Better Dividend Stock INDV or VTRS?
Indivior PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Viatris, Inc. offers a yield of 3.76% to investors and pays a quarterly dividend of $0.12 per share. Indivior PLC pays -- of its earnings as a dividend. Viatris, Inc. pays out 90.63% of its earnings as a dividend. Viatris, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios INDV or VTRS?
Indivior PLC quarterly revenues are $314M, which are smaller than Viatris, Inc. quarterly revenues of $3.8B. Indivior PLC's net income of $42M is higher than Viatris, Inc.'s net income of -$128.2M. Notably, Indivior PLC's price-to-earnings ratio is 35.28x while Viatris, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Indivior PLC is 3.79x versus 1.07x for Viatris, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INDVIndivior PLC3.79x 35.28x $314M $42M VTRSViatris, Inc.1.07x -- $3.8B -$128.2M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock a Good Buy Now?
eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…
Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
71
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
Buy
54
LGIH alert for Jan 10
LGI Homes, Inc. [LGIH] is up 13.81% over the past day.
